Same result when I sent an email to dmaclellan@radient-pharma.com -- it bounced back within five minutes with this error:
The domain name of the email address is not valid Check the "radient-pharma.com" part of the email address for misspellings or missing letters.
Anyone who doubts this can try it themselves.
Radient-pharma is dead. I don't think MacLellan is President, I don't think there is any current attempt to restructure or reorganize Radient, and I don't think RXPC shares will ever trade again.
I don't believe message-board "Investigative Longs" who say otherwise and I don't believe what CEO's say in emails or PR's or interviews. I only believe what I read in SEC filings. I believe Radient Pharmaceuticals is insolvent and their stock registration is revoked because that's what the company stated in their final 8K.
The odds of rising from THOSE ashes are astronomically poor. I think that anyone who read that 8K and still held onto RXPC stock does not understand the stock market.
This is all fun and games emailing MacLellan and trying to track down Charter and thinking wishfully on message boards, but I don't see how RXPC could be deader than this. "Insovlent" is not a vague word. It is a specific word. And Stock Registration Revocation is not a vague concept.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.